Detection of anticentromere antibodies using recombinant human CENP-A protein

Arthritis and Rheumatism

Volumn 39, Issue 5, 1996, Pages 863-867

  Sun, Dongxu ^a   Martinez, Antigona ^a   Sullivan, Kevin F ^b   Sharp, Gordon C ^c   Hoch, Sallie O ^a  

^a AGOURON PHARMACEUTICALS INC   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BACULOVIRUS; CARBOXY TERMINAL SEQUENCE; CENTROMERE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TARGETING; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BACULOVIRIDAE; CENTROMERE; CHROMOSOMAL PROTEINS, NON-HISTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; INSECTS; RECOMBINANT PROTEINS; SCLERODERMA, SYSTEMIC;

EID: 0029924604     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390520     Document Type: Article

References (15)

1. Rothfield NF: Autoantibodies in scleroderma. Rheum Dis Clin North Am 18:483-498, 1992
2. Verheijen R: B-cell epitopes of scleroderma-specific autoantigens. Mol Biol Rep 16:183-189, 1992
3. Earnshaw WC, Rothfield N: Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma. Chromosoma 91:313-321, 1985
4. Guldner HH, Lakomek HJ, Bautz FA: Human anti-centromere sera recognise a 19.5 kD non-histone chromosomal protein from HeLa cells. Clin Exp Immunol 58:13-20, 1984
5. Sullivan KF, Hechenberger M, Masri K: Human CENP-A contains a histone-H3-related histone fold domain that is required for targeting to the centromere. J Cell Biol 127:581-592, 1994
6. Billings PB, Martinez A, Haselby JA, Hoch SO: Protein blot assays specific for the discrimination of the centromere autoantigen, CENP-A, from human cells. Electrophoresis 14:909-916, 1993
7. Vázquez-Abad D, Wallace S, Senécal J-L, Joyal F, Roussin A, Earnshaw WC, Rothfield N: Anticentromere autoantibodies: evaluation of an ELISA using recombinant fusion protein CENP-B as antigen. Arthritis Rheum 37:248-252, 1994
8. Verheijen R, de Jong BA, Oberye EH, van Venrooij WJ: Molecular cloning of a major CENP-B epitope and its use for the detection of anticentromere autoantibodies. Mol Biol Rep 16: 49-59, 1992
9. Stahnke G, Meier E, Scanarini M, Northemann W: Eukaryotic expression of recombinant human centromere autoantigen and its use in a novel ELISA for diagnosis of CREST syndrome. J Autoimmun 7:107-118, 1994
10. Sugimoto K, Migita H, Hagishita Y, Yata H, Himeno M: An antigenic determinant on human centromere protein B (CENP-B) available for production of human-specific anticentromere antibodies in mouse. Cell Struct Funct 17:129-138, 1992
11. Bejarano LA, Bolivar J, Valdivia MM: Anticentromere antibody specific to human cells directed against the CENP-B autoantigen. Cytogenet Cell Genet 63:54-58, 1993
12. Kallenberg CGM, Wouda AA, Hoet MH, van Venrooij WJ: Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634-641, 1988
13. Weiner ES, Hildebrandt S, Senécal J-L, Daniels L, Noell S, Joyal F, Roussin A, Earnshaw W, Rothfield NF: Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease: a prospective study. Arthritis Rheum 34:68-77, 1991
14. Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ: Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 35:688-693, 1992
15. Herrick AL, Heaney M, Hollis S, Jayson MI: Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis 53:540-542, 1994